CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Thalys Medical Technology Group Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Thalys Medical Technology Group Corp
No.1310 Jinshan Avenue
Dongxi Lake District
Phone: +86 2783386378p:+86 2783386378 WUHAN, HUB  430040  China Ticker: 603716603716
Business Summary
Thalys Medical Technology Group Corp, formerly Thalys Medical Technology Inc, is a China-based company principally engaged in the provision of intensified distribution business and simple sales business and the research, design, manufacture and distribution of independent in vitro diagnostic products. Its product type includes purchased reagents and consumables, self-produced reagents and consumables, as well as purchased equipment. The Company mainly operates its business in domestic markets, with Hubei, Hunan, Jiangsu, Henan and Shanghai province as its major markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
5047 Medical, dental, and hospital equipment and supplies
2835 In vitro and in vivo diagnostic substances
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager WeiWen 47 7/1/2015
Chief Financial Officer YanShen 46 1/20/2023 1/20/2023
Deputy General Manager, Director LiFan 41 12/7/2022 7/1/2015
10 additional Officers and Directors records available in full report.

Business Names
Business Name
603716
Beijing Jingyang Tonewall Technology Development

General Information
Number of Employees: 1,474 (As of 12/31/2022)
Outstanding Shares: 201,323,345 (As of 1/29/2024)
Shareholders: 27,446
Stock Exchange: SHA
Fax Number: +86 2783084202


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 23, 2024